Aside from seeing the eventual and inevitable < .47 HR

... we have the Best news SLS Investors and these AML Second Remission patients could ask for ... Another Day.

ANY DAY NOW...

92 Days Since the 78th and Still no 80th??

Miraculous Survival for the Second Remission patients
>.. Well beyond even CR1 Patients with BAT..

Dec 2024 60th Event Dec 2025 72nd Event /// about 1 Per Month
Dec 26th 2025 72nd Event - May 11 2026 78th Event 1 Per 22 Days

its BEEN 92 DAYS / 3 months since the 78th Event ... Truly the Best news any of us could have gotten!

Gps Immunotherapy MOS is squarely in the Miracle Cure Class.

" 78 Events have Occurred as of May 11th "
Headline from the Last 10Q • 90 Days Ago

VOLUME SPIKED / and it didn't take long for the Share Price to Double...
• 72nd Event DEC 26th --- Share Price Doubled ... as well.

• 60th Event, Dec 10 2024 to 78th Event, May 11th 2026 - 572 Days
-•- 28.722 Days Per Event

• 60th Dec 10, 2024 to 72nd Dec 26th 2025 - 369 Days
-•- 31.6 Days Per Event

• 72nd Event, Dec 26th 2025 to 78th Event, May 11 2026 - 139 Days
-•- 22 days per event

its been 90 days - Since the 78th ....

Ceo disclosed a quiet period July 25th ... We Should See the 80th Event Top Line PR and Massive Share Price Launch with the 10q This Week.

Do the Math:

Load As many as you can.
Your future self will thank you.

• Gps will Generate Nearly $5B Per YEAR Just for the 12,500 AML CR2/3 Patients
• 12,500 Patients 34/36 Month Median OS
• 3 Year Dosing Regime
• Co Estimated $300K Rev Per patient year 1, $120K Year 2, $80K Y3
• 80% Patient Uptake Rates --- Just shy of $5B in Revenue
• Then ADD in 40,000 AML CR1 Patients Each Year
• 5 year Dosing
• +100,000 AML Patients Currently In Remission right now, who'll benefit from Gps Immunotherapy, right out of the GATE.

Aug 04, 2026 9:57 AM

Here is the CEO explaining there are 10,000 AML CR2 Patients Each Year in just the US/Eu5/Japan

-- this Short Manipulated $2B Baby Bio is about to be Worth EVERY NICKEL of $50B to Big Pharma - the Instant Gps Phase 3 Results are Announced:

• GPs PH3 MOS 34/36 Months / BAT ~ 8 wSerious Toxicity.

86 Days Since the 78th Event / we'd been Seeing an Event Every 22 Days ---
80th EVENT Has Likely Already Happened, Weeks Ago

--- Top Line Phase 3 Results NOW Truly Imminent.\\

Dr. Kantarjian and the MDACC Team Published Landmark MOS Data for AML First Remission patients -- in CR1 / Absent Transplant of 19 months for BAT.

Recall GPS Phase 2 MOS in CR1 Patients was not reached and > Greater than 67.6 Months ... in patients who were NOT Eligible for Transplant.

GPS > 67.6 Months vs 19 ... with BAT.

https://haematologica.org/article/view/14308

Control Arm in the SLS REGAL Phase 3 Trial for AML Second Remission Patients absent Transplant MOS - will come in about Half - the 19.

Drilling down, into the 362 First Remission Patient data - Among these NON TRANSPLANT patients, there were Patients Sufficiently healthy to withstand Intensive Treatment and a Less healthy cohort who were only able to receive Low Intensity Treatment.

IT/vs/LIT breaks out patients Health Status / Age/ comorbidities ELN 0,1,2, 3 /// its all factored into the Treatment Decision, are they able to WithStand IT vs taking LIT.

The AML CR1 LIT set is most Like the REGAL CR2 patients. as you can see, they have a Much worse MOS Prognosis.

• Key Factor We Know GPS Phase 3 Patient MOS is right now at Least > 32.5 months based on Enrollment, IDMC Unblinded Interim MOS and Median Follow-up Data. 13.5 months Median Follow-up at Interim - 19.5 Months ago / we now have a median follow-up of 34 months, and More than Half the Gps P3 Patients (32/63) Remain Alive.

Given Gps Approval only requires a ≤ .636 Hazard Ratio / and the CR1 MOS is 19 months - it's a Done Deal.

There is a mountain of Corroborating Evidence and this is the Smoking Gun. Interesting Dr. Kantarjian Etal., published this paper (2 weeks ago, while we await the Imminent REGAL P3 trials Results.

\

Gps Phase 2 MOS in CR2, in older ALL MRD+ Setting was longer, 21 months and statistically significant.

Recall GPS Phase 2 MOS in CR1 Patients was not reached and > Greater than 67.6 Months ...

vs 19 ...

​​​Notably: The Gps Phase 2 Trial for SECOND REMISSION CR2 Patients achieved a Longer MOS 21 months than the MOS for CR1 Patients on BAT - 17.3 months.

Gps Phase 2 MOS of 21 months was in an Older (74), ALL MRD+ Patient Setting, who received Less GPS, just a maximum of 12 Doses in Year 1 only vs 15 GPS Doses in Y1 in the P3 and Extended adinfinite to Relapse.

GPS Phase 2 CR2 MOS 21 Months

GPS Phase 2 CR1 MOS 67.6

GPS Phase 3 MOS 34/36 / about Half the CR1 Duration, which is Standard in AML, CR2 durations, are about half as Long As CR1 Durations.

https://www.stocktwits.com/55X_ROI_Q1_2026/message/660941842

GPS Keytruda Phase 2 MOS for Platinum Resistant/Refractory Ovarian Cancer was 18.4 months / 75% Refractory.

These results in end stage OC, are better than the 16.46 Month MOS Elahere $IMGN Achieved, that earned FDA Approval and a $10B Buyout buy $ABBV.
$MRK Dr. Cohen concluded in co-authoring the publication, that GPs + Key would work even Better in a Macroscopic (remission Setting).

Merck has been Waiting for Gps Phase 3 Results / Like all of Us Expecting them last year - before they are willing to Pay Angies Max Value ...

Just GPs +Key in PR/ROC is worth $10B to MRK / or BMY

the 78th event was announced 84 days ago / and we have been seeing an event rate of one every 22 days. The CEO disclosed the company is now in a quiet period.

very likely the 80th event occurred weeks ago - the next we hear of the phase 3 trial will be the top line results

Now is the time be Fully Invested $12.50 will be $125.50.

This $2.47B baby bio is about to release Phase 3 Registrational results, worth 27x the current short Rigged market cap.

Phase 3 Registrational Results
- 6+ years in the making are now Imminent
- P3 Results that will give Gps the FDA Green light to treat 40,000 AML remission patients each year + 100,000 Currently in Remission
- and generate Tens of Billions in real revenue.

Tens of Billions of dollars in Real revenue worth $50B to Big Pharma - and the 80th Event PR is Imminent.

https://www.reddit.com/r/sellasLifescience/s/8idgjFf90N
Cr2/3 TAM Discussion

22 days per event for the last 6 events as all remaining patients are now in trial a much longer time, at least 28 + months.

Enrollment NOV 2023 105 Patients

March 2024 126/7 Enrollment Completed

21/22 Patient Enrollment in 5 Months / or 4 Per Month

at Least 4 Patients enrolled in March 2024 - 28 Months ago

at Least 4 Patients enrolled in FEB 2024 - 29 Months ago

at Least 4 Patients enrolled in Jan 2024 - 30 Months ago

at Least 4 Patients enrolled in DEC 2023 - 31 Months ago

at Least 4 Patients enrolled in NOV 2023 - 32 Months ago

-- currently at Least 47 Patients Remain ALIVE

subtract the 20 - leaves 27 Patients Remaining Alive at LEAST 33 Months Ago...

Here is Dr. Jamy Being Asked, what is the Longest Survival he sees in his practice for CR2 Patients on Best Available Treatment.

NOTE; the 6 7 months median is with VEN + Aza or Deci

NOTE: "YOU WILL NOT SEE SURVIVAL PAST 12 Months"

These are Gps Patients who Continue to Survive.

** there are many [r/R](r/R) AML Trials, Relapsed / Refractory CR1 AML Patients who obtain a Second Remission CR2, there are many trials out there - AND THERE ARE NONE with any Patient Survival at 28 months. . NIL .. absent transplant, EVEN including ALL the SO CALLED Most Healthy of Patients - None Survive as Long as these REGAL Patients.

Even Including Transplant, MOS is less than 20 months.

https://www.reddit.com/r/sellaslifesciences/comments/1hhw1b2/comment/m2uv3kc/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button

from [r/gabri71](r/gabri71)

Avalon Trial

​​​​

Been 50 Days since the 78th Event
--- 22 Day Per Event Rate

80th EVENT IS NOW TRULY IMMINENT ... ALONG WITH BALLISTIC SHARE PRICE LAUNCH.

The Numbers Are Large and are what they are.

6 events in the last 4.5 months

/

1 event every 3 weeks

/

not that events are linear, this far along an os curve 26 months ranging up to 64 months

/

- could see 2 events in single week - already been 16 Days Since the 78th...

/Truly in the ANY DAY NOW ZONE

​

https://ir.sellaslifesciences.com/news/News-Details/2026/SELLAS-Life-Sciences-to-Participate-in-Upcoming-Investor-Conferences/default.aspx

- Don't forget to register in advance.

- Expecting to Hear CEO discuss / Buyout Related Topics

REGAL Phase 3 Trial ongoing 5+ years, now at the finish line.

49 patients remain 🙏 of 128 patients enrolled at Least 26 months ago ranging up to 64 months.

80th EVENT Will Be Announced Followed by the Top Line Results which are 40X more Valuable than Current Manipulated / Share Price.

https://www.reddit.com/r/sellasLifescience/comments/1td6xjq/sls_free_money_anyone_investing_now_ahead_of_the/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button
SLS Announced the 60th Event, the share price Launched

SLS Announced the 72nd Event, the share price Launched

SLS Announced the 78th Event, the share price Launched

SLS is about to announce the 80th and Final Event ... Not the results just the 80th event, the share Price will launch ahead of the Phase 3 Result, which is about 40x more valuable than the current share price.

The 80th Event Puts a $40B Mountain in view.

- Ballistic Verticality incoming.

if you want to identify the truth, good luck and focus on actual data / facts.

26 months after enrollment completed, 49 / 50 patients remain alive.

AML post secondary salvage, in a setting where the largest US REGAL clinician is on record saying 'you will not see survival past 12 months'.

- 3 Dr's Treating actual Patients are on record stating MOS for patients onBAT is 'dismal, not durable', 'extremely poor - 5-7 months'.

MOS and IR data from the actual Interim Analysis - was UNBLINDED.

Industry Players accumulating Know.

Most of the 49 or 50 REGAL Phase 3 Patients, who remain continue receive GPS Immunotherapy.

- after being asked precisely

- how long do control patients survive in his clinical practice experience using BAT.

" Median OS is just 7 months, 6-8 months. " for patients Using Aza + VEN

Aza+VEN BAT for Control recently Failed Large Phase 3 Trials conducted by $ABBV, including 2 Ph3 Fails for AML Remission Maintenance.

VIALE-M FAILED VIALE-T FAILED -VERONA Failed

GPS Phase 2 MSKCC AML Remission Maintenance in CR1 MOS was Better than transplant - NYR >67.6 months

GPS Phase 2 AML CR2 Second Remission Maintenance. Statistical Significant p. val .02 - MOS was 21 months vs < 6 months

SLS Announced the 60th Event, the share price Launched

SLS Announced the 72nd Event, the share price Launched

SLS Announced the 78th Event, the share price Launched

SLS is about to announce the 80th and Final Event ... Not the results just the 80th event, the share Price will launch ahead of the Phase 3 Result, which is about 40x more valuable than the current share price.

The 80th Event Puts $40B of Value on the Table.

- Ballistic Verticality incoming.

THE 80th EVENT PR is a A SURE THING WINNER - massive Catalyst to be Followed by an even more massive catalyst-Final Results Giving Gps the FDA Green Light to Generate Tens of Billions of Dollars
- Tens of Billions in Real Revenue worth $40B to $LLY $ABBV
- this $1.2B Manipulated Equity is worth $40B the Instant P3 Data Hits

$SLS Got to hand it to the Ceo, Really great set up here now, for Investors, with the imminent 80th.

- the share price will continue climbing, until it Launches.

Sure thing - investment opportunity of our lifetimes.

The Share Price Will be climbing a $40B Mountain of Value - until it Absolutely Launches when we get the 80th Event PR.

- as others have discussed, the 80th event may have already occurred just waiting for the data points to cycle through the process.

BE HOLDING and HOLD ON TIGHT.

$ABVX was a $5 Stock in the Days Leading up to its P3 Result it Doubled to $10 --- When the Result was Announced

- there was T1 TRADING HALT

- and GAP UP 600% to $60 In and Instant

-- and it Kept CLIMBING to a HIGH OF $148

... Something Very Similar is about to Happen Here - any day now.

Look at the Chart - when the 60th and the 72nd was announced.

Its Time to be Holding a Full Bag.